AGC Partners Advises STACS DNA on Its Investment From InVita Healthcare Technologies

Transaction Details

AGC Partners is pleased to announce that its client, STACS DNA, the world leader in sexual assault kit tracking and software provider to the largest forensic DNA labs in North America, has received an investment from InVita Healthcare Technologies, a portfolio company of Riverside Company. This represents AGC's 9th cross-border and 11th software deal in 2021. The STACS and InVita partnership will enable STACS DNA to further expand into the healthcare market with its Track-Kit for tracking sexual assault kits and newborn screening specimens, and the STACS laboratory information management system. With a team led by Fred Joseph, AGC Partners acted as the sole financial advisor to STACS DNA.

To view the announcement by Riverside, click here.

AGC Partners Advises STACS DNA on Its Investment From InVita Healthcare Technologies

Testimonial

Led by Fred, Team AGC did an amazing job from project launch to close date. Navigating through this maze of rather complex steps, especially during COVID, was somewhat intimidating but AGC guided and supported us through the whole process. I just can't see how we would have been able to plow through this critical work without the sound advice of M&A advisors of that caliber. Fred was able to translate what made STACS DNA a leader in its field into a compelling and concrete story for potential investors and conducted this exercise where we ultimately moved forward with a best-in-class partner. AGC came highly recommended, and I now see why. I would recommend them without reservation. It was a pleasure working with Fred, Daniel, Zack and Patrick and praise all the great work they did for us.

Jocelyn Tremblay, President and COO, STACS DNA

Related Insights

Get in touch and experience the AGC difference